研究生: |
甘麗婷 Li-Ting Kan |
---|---|
論文名稱: |
應用生物相容支架材料誘導人體脂肪幹細胞形成組織工程軟骨 Application of Bio-composite Scaffold in Tissue Engineered Cartilage by Inducing Human Adipose Tissue-derived Stem Cells |
指導教授: |
洪伯達
Po-Da Hong |
口試委員: |
戴念梓
Nian-Tyzz Dai 高震宇 Jen -Yu Cako 劉念先 Nian-Sian Liou |
學位類別: |
碩士 Master |
系所名稱: |
應用科技學院 - 醫學工程研究所 Graduate Institute of Biomedical Engineering |
論文出版年: | 2010 |
畢業學年度: | 98 |
語文別: | 中文 |
論文頁數: | 61 |
中文關鍵詞: | 幹細胞 、組織工程 、生物相容材料 |
外文關鍵詞: | stem cells, Tissue Engineering, Bio-composite Scaffold |
相關次數: | 點閱:338 下載:6 |
分享至: |
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報 |
本論文利用脂肪組織中取得具有分化能力的脂肪幹細胞(hASCs)結合生
物相容材料支架來誘導人體脂肪幹細胞形成組織工程軟骨。本實驗中評估
三種以明膠為主的細胞載體材料,應用在幹細胞分化成軟骨的可行性。本
實驗的主要支架明膠(gelatin)是一種具有良好的生物相容性材料,另外選擇
加入第ㄧ型膠原蛋白 (collagen I) 、第二型膠原蛋白(collagen II),並且加
入聚己內酯(PCL),形成gelatin/collagen II:PCL(GCII), gelatin:PCL(GP),
gelatin/collagen I:PCL(GCI) 能有效控制支架在細胞培養過程中,產生高度
的降解,維持其穩定性。並探討幹細胞在不同支架的生長及分化的情形。
在掃描式電子顯微鏡及螢光顯微鏡和細胞生長曲線鑑定下, 證明材料具
有良好的生物相容性。在脂肪幹細胞的誘導分化能力測定,免疫螢光染色
的結果顯示脂肪幹細胞在人工支架的微環境下,有被誘導走向軟骨細胞分
化的情形,且細胞表現量隨著時間而增加。另外,利用Alcian blue stain 和
DMMB assay 測定葡萄糖糖胺聚合糖分析,在GP 和GCII 有較多的表現
量。藉由Sirius red stain 來分析誘導後的軟骨中膠原蛋白的種類,使用可
見光/紫外光光譜儀測定其吸收值(波長:350nm; 540nm),結果顯示誘導後的
軟骨所分泌的膠原蛋白以第ㄧ型膠原蛋白為主。並利用Von Kossa stain 來
探討長時間後的軟骨基質鈣化(chondralcalcification)的情形,在誘導後第
三十天,鈣化出現在軟骨細胞周圍區。
This study investigated the induction of human adipose tissue-derived stem
cells (hASCs) into chondrocytes, which made a possible source for cartilage
tissue engineering in clinical therapy. The hASCs were cultured on three
different biocompatible biomaterial groups including gelatin/collagen I: PCL
(GCI), gelatin/collagen II:PCL (GCII) and gelatin:PCL (GP). Considering the
high degradability of natural biomaterials, the addition of PCL for formulation
of scaffolds is necessary to resist absorption in vitro. In addition, we
characterized the attachment, growth and differentiation abilities of hASCs in
biomaterials by SEM, fluorescence microscopy and cell growth curve in vitro.
The immunofluorescence data showed that the hASCs were differentiated with
the increasing time on biocomposite membrane groups. For investigation of
cartilage differentiation, alcian blue staining and dimethylmethylene blue
(DMMB) assay were used for both quality and quantity evaluation of
glycosaminoglycans. The results showed that the groups of gelatin and GCII
contained more glycosaminoglycans than GCI. For further distinguishing
distinct collagen types produced by chondrocytes based on different
biocomposite membranes, sirius red staining was used and type I collagen
showed the absorbance at 540 nm and type II collagen at 350nm with
UV-visble spectrophotometer. We demonstrated that the chondrocytes release
mainly type I collagen on all biocomposite membranes. In detecting the long
term expression of calcium accumulation in differentiated chondrocytes using
von kossa stain, chondral calcification represented after induction of
chondrocyte differentiation on biocomposite membranes for 30 days
[1] Lanza, R.P., Langer, R., Vacanti, J., “Principles of Tissue Engineering”, 2nd
ED, Academic Press, 2000.
[2] M. Ueda. I. Tohnai. and H. Nakai. “Tissue engineering research in oral
implant surgely.” Artificial Organs. 25(3):164-71. 2000
[3] P. D. Benay, J. D. Shaffer, Dedifferentiated chondrocytes reexpress the
differentiated collagen phenotype when cultured in agarose gels, Cell, 30,
215-224, 1982
[4] P. A. Zuk et al. “Tissue Engineering” 2001.
[5] C.F. Chang, M.W. Lee, P.Y. Kuo, Y.J. Wang, Y.H. Tu, S.C. Hung,
Threedimensional collagen fiber remodeling by mesenchymal stem cells
requires the integrin–matrix interaction, J. Biomed. Mater. Res. A. 80 (2007)
[6] Perrin, D. E. & English, J. P. Polycaprolactone. In: Domb, A. J., Kost, J. & Wiseman, D. M., editors. Handbook of Biodegradable Polymers. Australia:
Harwood Academic; p. 63-77 (1998).
[7] R.P., Langer, R., Vacanti, J., “Principles of Tissue Engineering”, 2nd , pp.671-682 Academic Press, Tokyo, samDiego, 1999.
[8] Vacanti, C. A. & Vacanti, J. P. Bone and cartilage reconstruction. In: Lanza,R., Langer, R., Chick, W. (eds.) Principles of Tissue Engineering. New York:R.G. Landes Co., p. 619-31 (1997).
[9] G. Chen. I. Ushida. and T. Tateishi. ‘Poly(D.L-latic-co-glycolic acid)
sponge hybridized with collagen microsponges and deposited apatite
particulates. J. Biomed. Mater. Res. 57. 8-14. 2001
[10] Babensee, J. E., Anderson, J. M., Melntire, L. V. & Mikos, A. G. Host
45response to tissue engineered devices. Adv Drug Deliv Rev. 33:111-39 (1998).
[11]A. A. Ignatius. and L.E. Claes. "1n vitro biocompatibility of bioresorbable
polymers: poly(L. DL-lactide) and poly(D .L-latide-co - glycolide).
Biomaterials. 17. 831-39. 1996
[12] Griffon DJ, Sedighi MR, Schaeffer DV, Eurell JA, Johnson AL, Acta
Biomaterials. 2006, 2 : 313-20.
[13] Wang K, Healy KE, Elenz DR, Nam EK, Tasi DC, Thomas CH, Tissue
Eng, 1999, 5 : 35-51.
[14] 黃玲惠. 膠原蛋白生物技術. 化工技術第四卷第七期. 1996
[15] T. Kimura, N. Yasai, S. Chsawa, Chondrocytes mebedded in cololagen
gels maintain cartilage phenotype during long term cultures, Clim Orthop Rel
Res, 1984, 186:231.
[16] S. Nehrer, H. A. Breinan, A. Ramappa, G. Young, S. Shortkroff, L. K.
Louie, Matrix collagen type and pore size influence behaviour of seeded
cannine chondrocytes, Biomaterials, 18, 769-776, 1997
[17] J. S. Pieper, P. M. van der Kraan, T. Hafmans, Crosslinked type Ⅱ
collagen, Biomaterials, 83, 3183-3192, 2002.
[18] Ma J, Wang H, He B, Chen JT, Biomaterials, 2001, 22 : 2563-7.
[19] Harley BA, Hastings AZ, Yannas IV, Sannino A., Biomaterials, 2006, 27,
866-74.
[20] Widmer, M. S. & Mikos, A. G. Fabrication of biodegradable polymer
scaffolds for tissue engineering. In: Patrick, Jr. C. W., Mikos, A. G. & McIntire,L. V., editors. Frontiers in Tissue Engineering. New York: Elsevier Science; p.107-20 (1998).
[21] Walker MR., Patel KK., Stappenbeck TS.: The stem cell niche. Pathology.
217: 169–180, 2009.46
[22] Kim WS., Park BS., Sung JH., Yang JM., Park SB., Kwak SJ., Park JS.:
Wound healing effect of adipose-derived stem cells: acritical role of secretory
factors on human dermal fibroblasts. Dermatol Sci. 48:15–24, 2007.
[23] Chen, H. F., Kuo, H. C., Chien, C. L. , Shun, C. T., Yao, Y. L. , Ip, P. L. ,Chuang, C. Y., Wang, C. C., Yang, Y. S. & Ho, H. N. Derivation,
characterization and differentiation of human embryonic stem cells: comparing
serum-containing versus serum-free media and evidence of germ cell
differentiation. Human Reproduction 22(2):567-77 (2007).
[24] P.A. Zuk. M Zhu. H Mizuno. J. Huang. J.W. Futrell. A.J. Katz. P.
Benhaim. H.P. Lorenz. and M.H. Hedrick. "Muhiti1ineage Cells from Human
Adipose Tissue: Implications for cell-Based Therapies." Tissue Engineering. 7.
211-28.2001
[25] Rei Ogawa, Hiroshi Mizuno, Atsushi Watanabe, Makoto Migita,
Takashi Shimada, and Hiko Hyakusoku” Osteogenic and chondrogenic
differentiation by adipose-derived stem cells harvested from GFP transgenic
mice”(2003)
[26] Me’ lanie Vermette, Vale’ rie Trottier, Vincent Me’ nard, Lucie
Saint-Pierre Alphonse Roy, Julie Fradette “ Production of a new
tissue-engineered adipose substitute from human adipose-derived stromal
cells” February 2007
[27] Wobus, A. M., & Boheler, K. R. Embryonic stem cells: prospects for
developmental biology and cell therapy. Physiology Review 85:635-78 (2005).
[28] Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R.,
Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., and Marshak, D. R.
Science 284, 143–147. (1999)
[29] Jacobson, L. O., Marks, E. K., Robson, M. J., Gaston, E. O. & Zirkle, R. E.47Effect of spleen 59 protection on mortality following x-irradiation. J Lab ClinMed 34:1538–1543 (1949).
[30] Pittenger, M. F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R.,
Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S. & Marshak, D.R.
Multilineage potential of adult human
[31] F. Bany. R.E. Boynton. B. Liu. and J.M. Murphy. “ (‘Chondrogenic
Differentiation of Mesenchymal Stem Cells from Bone Manow:
Differentiation-Dependent Gene Expression of Matrix Components” Exp.
Cell Res.. 268, 189—200. 2001
[32] Im, G. I., Shin, Y. W. & Lee, K. B. Do adipose tissue-derived
mesenchymal stem cells have the same osteogenic and chondrogenic
potential as bone marrow-derived cells. Osteoarthritis Cartilage 13:845-53
(2005).
[33] Chunmeng, S. & Tianmin, C. Effects of plastic-adherent dermal
multipotent cells on peripheral blood leukocytes and CFU-GM in rats.
Transplant Proc. 36:1578-1581 (2004).
[34] Tuan RS, Boland G, Tuli R. Adult mesenchymal stem cells and
cell-based tissue engineering. Arthritis Res Ther 2003;5:32–45.
[35] Aigner T, Stove J. Collagens—major component of the physiological
cartilage matrix, major target of cartilage degeneration, major tool in cartilage repair. Adv Drug Deliv Rev 2003;55:1569–93.
[36] J. S. Johnna, A. G. Mikos, Review: tissue engineering for regeneration of
articular cartilage, Biomaterials, 21, 431-440, 2000.
[37] T. blunk. A. L. Sieminski. K J. Gooch. D. L. Courter. A. P. Hollander. A.
M Nahir. R Langer. G. V. Novakovic. and L E. Freed. “Differential effects of
growth factors on tissue-engineered cartilage.” Tissue Engineering. 8(l):73-84.48 2002
[38] 洪瑩真,製備聚己內酯/明膠支架並探討其性質及皮膚組織工程上的應
用,國立台灣科技大學高分子工程研究所(2008)
[39] Beatrice Jegalian & Eddy M. De Robertis , Alcian Blue Cartilage Staining
(Cell 71, 901-910, 1992)
[40] K. von der Mark, V. Gauss, H. von der Mark, P. Muller, Relationship
between cell shap and type of collagen synthesized as chondrocyte lose their
cartilage phenotype in culture, Nature, 267, 531-532, 1977